Strategic objectives of Health Regulatory Agencies: an international comparative study

• Autor(a) principal: Brito, Rodrigo Lino de
• Data de Publicação: 2019
• Outros Autores: Flexa, Raquel Gonçalves Coimbra
• Tipo de documento: Artigo
• Idioma: por; eng
• Título da fonte: Vigilância Sanitária em Debate
• Texto Completo: https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1271
• topic: Strategic Planning; Strategic Objectives; Health Regulation; Regulatory Agencies; Planejamento Estratégico; Objetivos Estratégicos; Regulação Sanitária; Agências Reguladoras

Introduction: This article presents a comparative panorama between the current strategic maps of three of the world’s major regulatory agencies, in order to allow the analysis of the future objectives of these entities, as well as to understand the alignments and particularities of each organization. Objective: To analyze and compare the strategic maps of the National Health Regulatory Agency in Brazil (Anvisa); the US Food and Drug Administration (FDA) in the United States; and the European Medicines Agency (EMA) in the European Union. Method: This is a qualitative research which used the content analysis method and the technique of meaning condensation to structure and interpret findings. Results: It can be seen that all the analyzed entities have, in the organization of their management, the definition of planning processes, with the design of strategic objectives in synthetic maps and focused on problems, declaring their strategy with clarity, conciseness and objectivity. In addition, the degree of homogeneity of issues, as well as a text that is coherent with the state of the art of the regulatory field, favor the alignment between such agencies, making possible a greater international regulatory convergence. Conclusions: Explaining the strategy in the right way helps to provide organizational management with systemic analysis, focus, direction and intentionality,which certainly influences the achievement of the expected results.